Nexalin Technology Inc (NXL) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Nexalin Technology Inc   (NASDAQ: NXL)
 

Nexalin Technology Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Nexalin Technology Inc 's inventory turnover ratio sequentially decreased to 0.17 in the second quarter 2026, unsurprisingly, as the Nexalin Technology Inc markets continue to deteriorate, and NXL's faces growing challenges to bring down its inventories. Nexalin Technology Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 2147 days, from 1177 days, in the Mar 31 2026 quarter.

Within Healthcare sector 371 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1946, from total ranking in the first quarter 2026 at 2151.

NXL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Nexalin Technology Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NXL Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 34.97 % 2.42 % -24.69 % 1.17 % 19.18 %
Y / Y Cost of Sales Growth -85.71 % -86.6 % 180.54 % -68.9 % 215.14 %
Inventory Turnover Ratio (TTM) 0.17 0.31 0.38 0.28 0.33
NXL's Total Ranking # 1946 # 2151 # 2016 # 2013 # 2033
Average inventory processing period 2139 1184 951 1303 1098
Seq. Inventory Growth 30.07 % 36.52 % -17.94 % -7.37 % -1.3 %
Seq. Cost of Sales Growth 79.64 % -91.36 % 432.65 % -82.71 % 68.45 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 164
Healthcare Sector # 372
Overall Market # 1946

Inventory Turnover Ratio Statistics
High Average Low
2.61 0.49 0.16
(Mar 31 2023)   (Dec 31 2023)



NXL Company Profile >> Back to NXL Efficiency Comparisons >> Compare NXL Inventory Turnover Ratio to its Competitors

Financial Statements
Nexalin Technology Inc 's Inventories $ 0 Millions Visit NXL's Balance sheet
Nexalin Technology Inc 's Cost of Revenues TTM $ 0 Millions Visit NXL's Income Statement
What are NXL's Sales? Visit NXL's Sales by Segment

Other Inventory Turnover Ratios
Nexalin Technology Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NXL's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NXL's Competitors
Inventory Turnover Ratio for NXL's Suppliers
Inventory Turnover Ratio for NXL's Customers

You may also want to know
NXL's Sales Growth Rates NXL's Pe Price to earnings ratio NXL's Receivables Turnover Ratio NXL's Stock Quote
NXL's Net Income Growth Rates NXL's Ps Price to Sales ratio NXL's Sales per Employee NXL's Asset Turnover Ratio
NXL's Net Margin NXL's Pb Price to Book ratio NXL's Financial Strength Ratios NXL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Aspire Biopharma Holdings Inc   0.34 $ 0.080  Millions$ 0  Millions
Guided Therapeutics Inc   0.32 $ 0.158  Millions$ 1  Millions
Invo Fertility Inc   0.29 $ 0.065  Millions$ 0  Millions
Outlook Therapeutics Inc   0.26 $ 0.985  Millions$ 4  Millions
Alpha Cognition Inc.  0.23 $ 1.250  Millions$ 6  Millions
Verrica Pharmaceuticals Inc   0.17 $ 0.400  Millions$ 2  Millions
Nexalin Technology Inc   0.17 $ 0.030  Millions$ 0  Millions
Femasys Inc   0.15 $ 0.898  Millions$ 6  Millions
Yubo International Biotech Limited  0.15 $ 0.004  Millions$ 0  Millions
Bioadaptives Inc   0.14 $ 0.006  Millions$ 0  Millions
Citius Pharmaceuticals Inc   0.07 $ 1.610  Millions$ 22  Millions
Adagio Medical Holdings inc   0.05 $ 0.089  Millions$ 2  Millions
Citius Oncology Inc  0.04 $ 0.821  Millions$ 21  Millions
Vireo Growth Inc.  0.03 $ 2.485  Millions$ 85  Millions

Date modified: 2026-09-04T10:34:40+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.